- mail us help@24marketresearch.com
- Int'l 1(332) 2424 294 (Int'l)
TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
The Asia Pacific Tranexamic Acid market size was valued at US$ 156.3 million in 2024 and is projected to reach US$ 204.8 million by 2030, at a CAGR of 4.6% during the forecast period 2024-2030.
Tranexamic acid is a synthetic amino acid derivative used as an antifibrinolytic medication to treat or prevent excessive blood loss in various medical conditions and surgical procedures.
The Asia Pacific tranexamic acid market is growing steadily, driven by increasing surgical procedures and awareness of its effectiveness in managing bleeding disorders. Japan leads with a 30% market share, followed by China at 25% and India at 20%. In 2023, surgical applications accounted for 55% of total consumption, with gynecological uses at 25% and trauma management at 15%. The market experienced a 7% growth in demand from the cosmetic industry for skin whitening applications. Key players include Daiichi Sankyo (Japan) and Emcure Pharmaceuticals (India), holding a combined 35% market share in the region. The industry is investing in novel formulations, with a 12% increase in R&D spending on extended-release preparations in 2023. Challenges include patent expirations, leading to a 15% increase in generic competition. The COVID-19 pandemic has driven a 10% rise in demand for managing complications in severe cases. The market is benefiting from expanding healthcare access in developing countries, with an 8% growth in rural healthcare initiatives incorporating tranexamic acid in emergency kits.
Report Includes
This report is an essential reference for who looks for detailed information on Asia Pacific Tranexamic Acid . The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Tranexamic Acid , including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user's requirements is also available.
This report aims to provide a comprehensive presentation of the Asia Pacific Tranexamic Acid , with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tranexamic Acid . This report contains market size and forecasts of Tranexamic Acid in Asia Pacific, including the following market information:
We surveyed the Tranexamic Acid manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
• China
• India
• Japan
• South Korea
• Australia
• Thailand
• Indonesia
• USP25
• BP2000
• Other
• Trauma
• Craniocerebral Trauma
• Menorrhagia
• Postpartum Hemorrhage
• Surgery
• Other Treatment
• Whitening Cosmetics
• CSL Behring
• Pfizer Inc.
• Bayer AG
• Fresenius Kabi
• Hikma Pharmaceuticals PLC
• Sun Pharmaceutical Industries Ltd.
• Jiangsu Hengrui Medicine Co., Ltd.
• Sichuan Med-Shine Pharmaceutical Co., Ltd.
• Shanghai Fosun Pharmaceutical Group Co., Ltd.
• Nippon Pharmaceutical Co., Ltd.
Including or excluding key companies relevant to your analysis.
The report also provides analysis of leading market participants including:
• Key companies Tranexamic Acid revenues in Asia Pacific market, 2019-2024 (Estimated), ($ millions)
• Key companies Tranexamic Acid revenues share in Asia Pacific market, 2023 (%)
• Key companies Tranexamic Acid sales in Asia Pacific market, 2019-2024 (Estimated),
• Key companies Tranexamic Acid sales share in Asia Pacific market, 2023 (%)
Key Points of this Report:
• The depth industry chain includes analysis value chain analysis, porter five forces model analysis and cost structure analysis
• The report covers Asia Pacific and country-wise market of Tranexamic Acid
• It describes present situation, historical background and future forecast
• Comprehensive data showing Tranexamic Acid capacities, production, consumption, trade statistics, and prices in the recent years are provided
• The report indicates a wealth of information on Tranexamic Acid manufacturers
• Tranexamic Acid forecast for next five years, including market volumes and prices is also provided
• Raw Material Supply and Downstream Consumer Information is also included
• Any other user's requirements which is feasible for us
Reasons to Purchase this Report:
• Analyzing the outlook of the market with the recent trends and SWOT analysis
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
• Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
• Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
• Distribution Channel sales Analysis by Value
• Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• 1-year analyst support, along with the data support in excel format.
1.1 Product Overview and Scope of Tranexamic Acid
1.2.1 Asia Pacific Market Size YoY Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 USP25
1.2.3 BP2000
1.2.4 Other
1.3.1 Asia Pacific Market Size YoY Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Trauma
1.3.3 Craniocerebral Trauma
1.3.4 Menorrhagia
1.3.5 Postpartum Hemorrhage
1.3.6 Surgery
1.3.7 Other Treatment
1.3.8 Whitening Cosmetics
1.4 Asia Pacific Market Growth Prospects
1.4.1 Asia Pacific Revenue Estimates and Forecasts (2019-2030)
1.4.2 Asia Pacific Production Estimates and Forecasts (2019-2030)
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 PESTEL Analysis
2.1.3 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
3.1 Asia Pacific Production by Manufacturers (2019-2023)
3.2 Asia Pacific Revenue Market Share by Manufacturers (2019-2023)
3.3 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Asia Pacific Average Price by Manufacturers (2019-2023)
3.5 Manufacturers Production Sites, Area Served, Product Type
3.6 Market Competitive Situation and Trends
3.6.1 Market Concentration Rate
3.6.2 Asia Pacific 5 and 10 Largest Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4.1 Asia Pacific Production
4.1.1 Asia Pacific Production YoY Growth Rate (2019-2023)
4.1.2 Asia Pacific Production, Revenue, Price and Gross Margin (2019-2024)
5.1 Asia Pacific
5.1.1 Asia Pacific Consumption by Country
5.1.2 Asia Pacific Sales, Consumption, Export, Import (2019-2023)
5.1.1 China
5.2.2 India
5.3.3 Japan
5.4.4 South Korea
5.5.5 Australia
5.6.6 Thailand
5.7.7 Indonesia
6.1 Asia Pacific Production Market Share by Type (2019-2024)
6.2 Asia Pacific Revenue Market Share by Type (2019-2024)
6.3 Asia Pacific Price by Type (2019-2024)
7.1 Asia Pacific Production Market Share by Application (2019-2024)
7.2 Asia Pacific Revenue Market Share by Application (2019-2024)
7.3 Asia Pacific Price by Application (2019-2024)
8.1 CSL Behring
8.1.1 CSL Behring Corporation Information
8.1.2 CSL Behring Product Portfolio
8.1.3 CSL Behring Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.1.4 CSL Behring Main Business and Markets Served
8.1.5 CSL Behring Recent Developments/Updates
8.2 Pfizer Inc.
8.2.1 Pfizer Inc. Corporation Information
8.2.2 Pfizer Inc. Product Portfolio
8.2.3 Pfizer Inc. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.2.4 Pfizer Inc. Main Business and Markets Served
8.2.5 Pfizer Inc. Recent Developments/Updates
8.3 Bayer AG
8.3.1 Bayer AG Corporation Information
8.3.2 Bayer AG Product Portfolio
8.3.3 Bayer AG Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.3.4 Bayer AG Main Business and Markets Served
8.3.5 Bayer AG Recent Developments/Updates
8.4 Fresenius Kabi
8.4.1 Fresenius Kabi Corporation Information
8.4.2 Fresenius Kabi Product Portfolio
8.4.3 Fresenius Kabi Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.4.4 Fresenius Kabi Main Business and Markets Served
8.4.5 Fresenius Kabi Recent Developments/Updates
8.5 Hikma Pharmaceuticals PLC
8.5.1 Hikma Pharmaceuticals PLC Corporation Information
8.5.2 Hikma Pharmaceuticals PLC Product Portfolio
8.5.3 Hikma Pharmaceuticals PLC Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.5.4 Hikma Pharmaceuticals PLC Main Business and Markets Served
8.5.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
8.6 Sun Pharmaceutical Industries Ltd.
8.6.1 Sun Pharmaceutical Industries Ltd. Corporation Information
8.6.2 Sun Pharmaceutical Industries Ltd. Product Portfolio
8.6.3 Sun Pharmaceutical Industries Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.6.4 Sun Pharmaceutical Industries Ltd. Main Business and Markets Served
8.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
8.7 Jiangsu Hengrui Medicine Co., Ltd.
8.7.1 Jiangsu Hengrui Medicine Co., Ltd. Corporation Information
8.7.2 Jiangsu Hengrui Medicine Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.7.3 Jiangsu Hengrui Medicine Co., Ltd. Main Business and Markets Served
8.7.4 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments/Updates
8.8 Sichuan Med-Shine Pharmaceutical Co., Ltd.
8.8.1 Sichuan Med-Shine Pharmaceutical Co., Ltd. Corporation Information
8.8.2 Sichuan Med-Shine Pharmaceutical Co., Ltd. Product Portfolio
8.8.3 Sichuan Med-Shine Pharmaceutical Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.8.4 Sichuan Med-Shine Pharmaceutical Co., Ltd. Main Business and Markets Served
8.8.5 Sichuan Med-Shine Pharmaceutical Co., Ltd. Recent Developments/Updates
8.9 Shanghai Fosun Pharmaceutical Group Co., Ltd.
8.9.1 Shanghai Fosun Pharmaceutical Group Co., Ltd. Corporation Information
8.9.2 Shanghai Fosun Pharmaceutical Group Co., Ltd. Product Portfolio
8.9.3 Shanghai Fosun Pharmaceutical Group Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.9.4 Shanghai Fosun Pharmaceutical Group Co., Ltd. Main Business and Markets Served
8.9.5 Shanghai Fosun Pharmaceutical Group Co., Ltd. Recent Developments/Updates
8.10 Nippon Pharmaceutical Co., Ltd.
8.10.1 Nippon Pharmaceutical Co., Ltd. Corporation Information
8.10.2 Nippon Pharmaceutical Co., Ltd. Product Portfolio
8.10.3 Nippon Pharmaceutical Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.10.4 Nippon Pharmaceutical Co., Ltd. Main Business and Markets Served
8.10.5 Nippon Pharmaceutical Co., Ltd. Recent Developments/Updates
9.1 Key Raw Materials Analysis
9.1.1 Key Raw Materials
9.1.2 Key Suppliers of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
9.3 Manufacturing Process Analysis of Tranexamic Acid
9.4 Industrial Chain Analysis
10.1 Marketing Channel
10.2 Distributors List
10.3 Customers
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12.1 Asia Pacific Production, Revenue Forecast (2024-2030)
13.1 Asia Pacific Forecasted Consumption of by Country
14.1 Asia Pacific Production, Revenue and Price Forecast by Type (2024-2030)
14.1.1 Asia Pacific Forecasted Production of by Type (2024-2030)
14.1.2 Asia Pacific Forecasted Revenue of by Type (2024-2030)
14.1.3 Asia Pacific Forecasted Price of by Type (2024-2030)
14.2 Asia Pacific Production, Revenue and Price Forecast by Application (2024-2030)
14.2.1 Asia Pacific Forecasted Production of by Application (2024-2030)
14.2.2 Asia Pacific Forecasted Revenue of by Application (2024-2030)
14.2.3 Asia Pacific Forecasted Price of by Application (2024-2030)
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Author List
16.4 Disclaimer
17.1 Note
17.2 Examples of Clients
Frequently Asked Questions ?
